Frontiers in Neurology (Sep 2022)
Toward individualized medicine in stroke—The TiMeS project: Protocol of longitudinal, multi-modal, multi-domain study in stroke
- Lisa Fleury,
- Lisa Fleury,
- Philipp J. Koch,
- Philipp J. Koch,
- Philipp J. Koch,
- Maximilian J. Wessel,
- Maximilian J. Wessel,
- Maximilian J. Wessel,
- Christophe Bonvin,
- Diego San Millan,
- Christophe Constantin,
- Philippe Vuadens,
- Jan Adolphsen,
- Andéol Cadic Melchior,
- Andéol Cadic Melchior,
- Julia Brügger,
- Julia Brügger,
- Elena Beanato,
- Elena Beanato,
- Martino Ceroni,
- Martino Ceroni,
- Pauline Menoud,
- Pauline Menoud,
- Diego De Leon Rodriguez,
- Valérie Zufferey,
- Nathalie H. Meyer,
- Philip Egger,
- Philip Egger,
- Sylvain Harquel,
- Sylvain Harquel,
- Traian Popa,
- Traian Popa,
- Estelle Raffin,
- Estelle Raffin,
- Gabriel Girard,
- Gabriel Girard,
- Gabriel Girard,
- Jean-Philippe Thiran,
- Jean-Philippe Thiran,
- Jean-Philippe Thiran,
- Claude Vaney,
- Vincent Alvarez,
- Jean-Luc Turlan,
- Andreas Mühl,
- Bertrand Léger,
- Takuya Morishita,
- Takuya Morishita,
- Silvestro Micera,
- Silvestro Micera,
- Olaf Blanke,
- Olaf Blanke,
- Dimitri Van De Ville,
- Dimitri Van De Ville,
- Dimitri Van De Ville,
- Friedhelm C. Hummel,
- Friedhelm C. Hummel,
- Friedhelm C. Hummel
Affiliations
- Lisa Fleury
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Lisa Fleury
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Philipp J. Koch
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Philipp J. Koch
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Philipp J. Koch
- Department of Neurology, University of Lübeck, Lübeck, Germany
- Maximilian J. Wessel
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Maximilian J. Wessel
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Maximilian J. Wessel
- Department of Neurology, University Hospital and Julius-Maximilians-University, Wuerzburg, Germany
- Christophe Bonvin
- Hôpital du Valais, Sion, Switzerland
- Diego San Millan
- Hôpital du Valais, Sion, Switzerland
- Christophe Constantin
- Hôpital du Valais, Sion, Switzerland
- Philippe Vuadens
- Clinique Romande de Réadaptation, Sion, Switzerland
- Jan Adolphsen
- Berner Klinik, Crans-Montana, Switzerland
- Andéol Cadic Melchior
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Andéol Cadic Melchior
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Julia Brügger
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Julia Brügger
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Elena Beanato
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Elena Beanato
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Martino Ceroni
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Martino Ceroni
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Pauline Menoud
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Pauline Menoud
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Diego De Leon Rodriguez
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Valérie Zufferey
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Nathalie H. Meyer
- Laboratory of Cognitive Neuroscience, INX and BMI, EPFL, Campus Biotech, Geneva, Switzerland
- Philip Egger
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Philip Egger
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Sylvain Harquel
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Sylvain Harquel
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Traian Popa
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Traian Popa
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Estelle Raffin
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Estelle Raffin
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Gabriel Girard
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland
- Gabriel Girard
- 0Department of Radiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
- Gabriel Girard
- 1Signal Processing Laboratory (LTS5), EPFL, Lausanne, Switzerland
- Jean-Philippe Thiran
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland
- Jean-Philippe Thiran
- 0Department of Radiology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
- Jean-Philippe Thiran
- 1Signal Processing Laboratory (LTS5), EPFL, Lausanne, Switzerland
- Claude Vaney
- Berner Klinik, Crans-Montana, Switzerland
- Vincent Alvarez
- Hôpital du Valais, Sion, Switzerland
- Jean-Luc Turlan
- Clinique Romande de Réadaptation, Sion, Switzerland
- Andreas Mühl
- Clinique Romande de Réadaptation, Sion, Switzerland
- Bertrand Léger
- Clinique Romande de Réadaptation, Sion, Switzerland
- Takuya Morishita
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Takuya Morishita
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Silvestro Micera
- 2The Biorobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Pisa, Italy
- Silvestro Micera
- 3Bertarelli Foundation Chair in Translational Neuroengineering, Centre for Neuroprosthetics and Institute of Bioengineering, School of Engineering, EPFL, Lausanne, Switzerland
- Olaf Blanke
- Laboratory of Cognitive Neuroscience, INX and BMI, EPFL, Campus Biotech, Geneva, Switzerland
- Olaf Blanke
- 4Department of Clinical Neurosciences, University of Geneva (UNIGE), Geneva, Switzerland
- Dimitri Van De Ville
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland
- Dimitri Van De Ville
- 5Medical Image Processing Lab, Center for Neuroprosthetics, Institute of Bioengineering, EPFL, Lausanne, Switzerland
- Dimitri Van De Ville
- 6Department of Radiology and Medical Informatics, University of Geneva (UNIGE), Geneva, Switzerland
- Friedhelm C. Hummel
- Defitech Chair of Clinical Neuroengineering, Neuro-X Institute (INX) and Brain Mind Institute (BMI), EPFL, Campus Biotech, Geneva, Switzerland
- Friedhelm C. Hummel
- Defitech Chair of Clinical Neuroengineering, INX and BMI, EPFL Valais, Clinique Romande de Réadaptation, Sion, Switzerland
- Friedhelm C. Hummel
- 7Clinical Neuroscience, Geneva University Hospital, Geneva, Switzerland
- DOI
- https://doi.org/10.3389/fneur.2022.939640
- Journal volume & issue
-
Vol. 13
Abstract
Despite recent improvements, complete motor recovery occurs in <15% of stroke patients. To improve the therapeutic outcomes, there is a strong need to tailor treatments to each individual patient. However, there is a lack of knowledge concerning the precise neuronal mechanisms underlying the degree and course of motor recovery and its individual differences, especially in the view of brain network properties despite the fact that it became more and more clear that stroke is a network disorder. The TiMeS project is a longitudinal exploratory study aiming at characterizing stroke phenotypes of a large, representative stroke cohort through an extensive, multi-modal and multi-domain evaluation. The ultimate goal of the study is to identify prognostic biomarkers allowing to predict the individual degree and course of motor recovery and its underlying neuronal mechanisms paving the way for novel interventions and treatment stratification for the individual patients. A total of up to 100 patients will be assessed at 4 timepoints over the first year after the stroke: during the first (T1) and third (T2) week, then three (T3) and twelve (T4) months after stroke onset. To assess underlying mechanisms of recovery with a focus on network analyses and brain connectivity, we will apply synergistic state-of-the-art systems neuroscience methods including functional, diffusion, and structural magnetic resonance imaging (MRI), and electrophysiological evaluation based on transcranial magnetic stimulation (TMS) coupled with electroencephalography (EEG) and electromyography (EMG). In addition, an extensive, multi-domain neuropsychological evaluation will be performed at each timepoint, covering all sensorimotor and cognitive domains. This project will significantly add to the understanding of underlying mechanisms of motor recovery with a strong focus on the interactions between the motor and other cognitive domains and multimodal network analyses. The population-based, multi-dimensional dataset will serve as a basis to develop biomarkers to predict outcome and promote personalized stratification toward individually tailored treatment concepts using neuro-technologies, thus paving the way toward personalized precision medicine approaches in stroke rehabilitation.
Keywords
- stroke
- precision medicine
- transcranial magnetic stimulation
- electroencephalography
- neuroimaging
- biomarkers